Form 4: Saul Centers Director James Page Lansdale Reports Acquisition of 2,000 Shares of Common Stock
SEC Filing Form 4
Director James Page Lansdale reports acquiring 2,000 shares of Saul Centers, Inc. common stock on May 17, 2024, and beneficially owning 2,576 shares.
Summary
- On May 21, 2024, James Page Lansdale, a director of Saul Centers, Inc., filed a Form 4 with the SEC.
- The report indicates that Mr. Lansdale acquired 2,000 shares of common stock on May 17, 2024, at a price of $0.
- These shares are restricted and vest in equal annual installments over three years, assuming continued service.
- Following the transaction, Mr. Lansdale beneficially owns 2,576 shares of common stock directly.
- The report also details Mr. Lansdale's holdings of various employee and director stock options with different exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard filing related to stock transactions by a company director. The acquisition of shares could be seen as a positive signal, but it's not a major event.
Positives
- The acquisition of shares by a director could be interpreted positively, signaling confidence in the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/08/2015 | Date of grant for Employee and Director Stock Options with an exercise price of $51.07, expiring on 05/08/2025. |
| 05/06/2016 | Date of grant for Employee and Director Stock Options with an exercise price of $57.74, expiring on 05/06/2026. |
| 05/05/2017 | Date of grant for Employee and Director Stock Options with an exercise price of $59.41, expiring on 05/05/2027. |
| 05/11/2018 | Date of grant for Employee and Director Stock Options with an exercise price of $49.46, expiring on 05/11/2028. |
| 05/03/2019 | Date of grant for Employee and Director Stock Options with an exercise price of $55.71, expiring on 05/03/2029. |
| 04/24/2020 | Date of grant for Director Stock Options with an exercise price of $50, expiring on 04/24/2030. |
| 05/07/2021 | Date of grant for Director Stock Options with an exercise price of $43.89, expiring on 05/07/2031. |
| 05/13/2022 | Date of grant for Director Stock Options with an exercise price of $47.9, expiring on 05/13/2032. |
| 05/12/2023 | Date of grant for Director Stock Options with an exercise price of $33.79, expiring on 05/12/2033. |
| 05/17/2024 | Date of transaction: James Page Lansdale acquired 2,000 shares of common stock. |
| 05/21/2024 | Date of filing: Form 4 filed with the SEC. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.